Importantly, patients with active renal disease exhibited statistically significantly higher mean levels of creatinine-normalized MCP-1 and VCAM-1, compared with the other SLE patients (Figure 2B, C); in contrast, urine CXCL16 was not as discriminatory (Figure 2A). This evidence concerns the gene CCL2 and kidney disorder.